Smruthi Organics receives approval from EDQM for Metformin Hydrochloride
Smruthi Organics Ltd has announced that the Company has got Certificate of Suitability (COS) approval by European Directorate for the Quality of Medicines & Health Care (EDQM) for the product Metformin Hydrochloride.
This certificate will strengthen the Company to enter the European Regulated Market for Metformin Hydrochloride. This certificate will have a substantial impact on its marketing capabilities in EU Markets.
The stock closed the day at Rs.62.35, up by Rs.1.40 or 2.30%. The stock hit an intraday high of Rs.63.90 and low of Rs.58.25.
The total traded quantity was 2925 compared to 2 week average of 4278.
